Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Capacity for the management of kidney failure in the International Society of Nephrology Eastern and Central Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)

C. Alparslan, J. Malyszko, FJ. Caskey, M. Aleckovic-Halilovic, Z. Hrušková, S. Arruebo, AK. Bello, S. Damster, JA. Donner, V. Jha, DW. Johnson, A. Levin, C. Malik, M. Nangaku, IG. Okpechi, M. Tonelli, F. Ye, V. Tesar, S. Racki, Regional Board and...

. 2024 ; 13 (1) : 29-42. [pub] 20240408

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013085

Delivery of care for kidney failure (KF) globally has a significant disparity; even in some countries, it means end of life for the person. The International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) tries to address gaps in KF care and standardize global nephrology care. From the third iteration of the ISN-GKHA, we present data for countries in the ISN Eastern and Central Europe region. The median prevalences of chronic kidney disease (12.8%) and treated KF (873.5 pmp) were higher than the global rates, respectively. Hemodialysis was the most preferred modality for KF in adults, whereas kidney replacement therapy was more balanced in children. Although most of the countries in the region had lower-middle-income and upper-middle-income levels, health expenditures for kidney health care were almost generally covered publicly. Nephrologists were responsible for the medical kidney care of people with KF in all countries. There was adequate infrastructure to provide all kinds of treatment for kidney care in the region. Regional characteristics such as high levels of obesity, smoking, and Balkan nephropathy as an endemic disease coupled with a shortage of workforce and finance continued to affect kidney care in the region negatively. By making organizational and legislative arrangements, partnerships with national authorities and societies may accelerate the improvement of kidney health care in the region.

Australasian Kidney Trials Network at the University of Queensland Brisbane Queensland Australia

Canada and Pan American Health Organization World Health Organization's Collaborating Centre in Prevention and Control of Chronic Kidney Disease University of Calgary Calgary Alberta Canada

Centre for Kidney Disease Research University of Queensland at Princess Alexandra Hospital Brisbane Queensland Australia

Clinic for Internal Diseases Department of Nephrology Dialysis and Transplantation University Hospital Center Tuzla Tuzla Bosnia and Herzegovina

Department of Kidney and Transplant Services Princess Alexandra Hospital Brisbane Queensland Australia

Department of Medicine University of Calgary Calgary Alberta Canada

Department of Nephrology 1st Faculty of Medicine Charles University and General Hospital Prague Prague Czech Republic

Department of Nephrology Dialysis and Internal Medicine Medical University of Warsaw Warsaw Poland

Department of Nephrology Dialysis and Transplantation University Hospital Center Rijeka Rijeka Croatia

Department of Pediatric Nephrology İzmir Democracy University School of Medicine İzmir Turkey

Division of Nephrology and Endocrinology The University of Tokyo Graduate School of Medicine Tokyo Japan

Division of Nephrology and Hypertension University of Cape Town Cape Town South Africa

Division of Nephrology and Immunology Faculty of Medicine and Dentistry University of Alberta Edmonton Alberta Canada

Division of Nephrology Department of Medicine University of British Columbia Vancouver British Columbia Canada

George Institute for Global Health University of New South Wales New Delhi India

Kidney and Hypertension Research Unit University of Cape Town Cape Town South Africa

Manipal Academy of Higher Education Manipal India

Population Health Sciences Bristol Medical School University of Bristol Bristol UK

School of Public Health Imperial College London UK

The International Society of Nephrology Brussels Belgium

Translational Research Institute Brisbane Queensland Australia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013085
003      
CZ-PrNML
005      
20240726151521.0
007      
ta
008      
240723s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.kisu.2024.01.006 $2 doi
035    __
$a (PubMed)38618499
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Alparslan, Caner $u Department of Pediatric Nephrology, İzmir Democracy University School of Medicine, İzmir, Turkey
245    10
$a Capacity for the management of kidney failure in the International Society of Nephrology Eastern and Central Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA) / $c C. Alparslan, J. Malyszko, FJ. Caskey, M. Aleckovic-Halilovic, Z. Hrušková, S. Arruebo, AK. Bello, S. Damster, JA. Donner, V. Jha, DW. Johnson, A. Levin, C. Malik, M. Nangaku, IG. Okpechi, M. Tonelli, F. Ye, V. Tesar, S. Racki, Regional Board and ISN-GKHA Team Authors
520    9_
$a Delivery of care for kidney failure (KF) globally has a significant disparity; even in some countries, it means end of life for the person. The International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) tries to address gaps in KF care and standardize global nephrology care. From the third iteration of the ISN-GKHA, we present data for countries in the ISN Eastern and Central Europe region. The median prevalences of chronic kidney disease (12.8%) and treated KF (873.5 pmp) were higher than the global rates, respectively. Hemodialysis was the most preferred modality for KF in adults, whereas kidney replacement therapy was more balanced in children. Although most of the countries in the region had lower-middle-income and upper-middle-income levels, health expenditures for kidney health care were almost generally covered publicly. Nephrologists were responsible for the medical kidney care of people with KF in all countries. There was adequate infrastructure to provide all kinds of treatment for kidney care in the region. Regional characteristics such as high levels of obesity, smoking, and Balkan nephropathy as an endemic disease coupled with a shortage of workforce and finance continued to affect kidney care in the region negatively. By making organizational and legislative arrangements, partnerships with national authorities and societies may accelerate the improvement of kidney health care in the region.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Malyszko, Jolanta $u Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
700    1_
$a Caskey, Fergus J $u Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK
700    1_
$a Aleckovic-Halilovic, Mirna $u Clinic for Internal Diseases, Department of Nephrology, Dialysis and Transplantation, University Hospital Center Tuzla, Tuzla, Bosnia and Herzegovina
700    1_
$a Hrušková, Zdenka $u Department of Nephrology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic
700    1_
$a Arruebo, Silvia $u The International Society of Nephrology, Brussels, Belgium
700    1_
$a Bello, Aminu K $u Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Damster, Sandrine $u The International Society of Nephrology, Brussels, Belgium
700    1_
$a Donner, Jo-Ann $u The International Society of Nephrology, Brussels, Belgium
700    1_
$a Jha, Vivekanand $u George Institute for Global Health, University of New South Wales, New Delhi, India $u School of Public Health, Imperial College, London, UK $u Manipal Academy of Higher Education, Manipal, India
700    1_
$a Johnson, David W $u Department of Kidney and Transplant Services, Princess Alexandra Hospital, Brisbane, Queensland, Australia $u Centre for Kidney Disease Research, University of Queensland at Princess Alexandra Hospital, Brisbane, Queensland, Australia $u Translational Research Institute, Brisbane, Queensland, Australia $u Australasian Kidney Trials Network at the University of Queensland, Brisbane, Queensland, Australia
700    1_
$a Levin, Adeera $u Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
700    1_
$a Malik, Charu $u The International Society of Nephrology, Brussels, Belgium
700    1_
$a Nangaku, Masaomi $u Division of Nephrology and Endocrinology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan
700    1_
$a Okpechi, Ikechi G $u Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada $u Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa $u Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa
700    1_
$a Tonelli, Marcello $u Department of Medicine, University of Calgary, Calgary, Alberta, Canada $u Canada and Pan-American Health Organization/World Health Organization's Collaborating Centre in Prevention and Control of Chronic Kidney Disease, University of Calgary, Calgary, Alberta, Canada
700    1_
$a Ye, Feng $u Division of Nephrology and Immunology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Tesar, Vladimir $u Department of Nephrology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic
700    1_
$a Racki, Sanjin $u Department of Nephrology, Dialysis and Transplantation, University Hospital Center Rijeka, Rijeka, Croatia
710    2_
$a Regional Board and ISN-GKHA Team Authors
773    0_
$w MED00203343 $t Kidney international supplement $x 2157-1724 $g Roč. 13, č. 1 (2024), s. 29-42
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38618499 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240723 $b ABA008
991    __
$a 20240726151514 $b ABA008
999    __
$a ok $b bmc $g 2125598 $s 1224948
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 13 $c 1 $d 29-42 $e 20240408 $i 2157-1724 $m Kidney international supplement $n Kidney Int Suppl (2011) $x MED00203343
LZP    __
$a Pubmed-20240723

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...